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Abstract
The inflammatory response to severe traumatic injury results in significant morbidity and mortality. Lymphocytes have
recently been identified as critical mediators of the early innate immune response to ischemia-reperfusion injury.
Experimental manipulation of lymphocytes following hemorrhagic shock may prevent secondary immunologic injury in
surgical and trauma patients. The objective of this study is to evaluate the lymphocyte sequestration agent FTY720 as an
immunomodulator following experimental hemorrhagic shock in a swine liver injury model. Yorkshire swine were
anesthetized and underwent a grade III liver injury with uncontrolled hemorrhage to induce hemorrhagic shock.
Experimental groups were treated with a lymphocyte sequestration agent, FTY720, (n=9) and compared to a vehicle
control group (n=9). Animals were observed over a 3 day survival period after hemorrhage. Circulating total leukocyte and
neutrophil counts were measured. Central lymphocytes were evaluated with mesenteric lymph node and spleen
immunohistochemistry (IHC) staining for CD3. Lung tissue infiltrating neutrophils were analyzed with myeloperoxidase
(MPO) IHC staining. Relevant immune-related gene expression from liver tissue was quantified using RT-PCR. The overall
survival was 22.2% in the vehicle control and 66.7% in the FTY720 groups (p=0.081), and reperfusion survival (period after
hemorrhage) was 25% in the vehicle control and 75% in the FTY720 groups (p=0.047). CD3
+ lymphocytes were significantly
increased in mesenteric lymph nodes and spleen in the FTY720 group compared to vehicle control, indicating central
lymphocyte sequestration. Lymphocyte disruption significantly decreased circulating and lung tissue infiltrating
neutrophils, and decreased expression of liver immune-related gene expression in the FTY720 treated group. There were
no observed infectious or wound healing complications. Lymphocyte sequestration with FTY720 improves survival in
experimental hemorrhagic shock using a porcine liver injury model. These results support a novel and clinically relevant
lymphocyte immunomodulation strategy to ameliorate secondary immune injury in hemorrhagic shock.
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Introduction
The immune system has evolved to respond to localized injury
and infection. Severe trauma and hemorrhagic shock result in
systemic activation of the immune system, initiating an inappro-
priate inflammatory response that leads to secondary host
ischemia reperfusion injury. Systemic inflammatory intensification
following injury can progress to acute respiratory distress
syndrome, systemic inflammatory response syndrome, and multi-
ple organ dysfunction syndrome [1]. Therapeutic manipulation of
the immunologic response to severe trauma may reduce associated
morbidity and mortality.
Lymphocytes are major components of adaptive immunity and
influence late immune dysfunction following severe injury [2,3,4].
Lymphocytes have also recently been identified as critical
mediators of the early innate immune response to ischemia-
reperfusion injury (IRI). Compelling pre-clinical investigation has
established the innate role of lymphocytes in renal [5], gut [6], and
liver [7,8] IRI. In a renal IRI model, genetically engineered mice
deficient in both CD4
+ and CD8
+ lymphocytes had substantially
less kidney dysfunction after renal ischemia than did wild-type
control mice [5]. Interestingly, mice deficient in CD4
+ and CD8
+
lymphocytes demonstrated less tissue neutrophil infiltration,
suggesting that lymphocytes orchestrate cell-mediated innate
responses to ischemia. Furthermore, lymphocytes have been
shown to rapidly accumulate in target organs following ischemia
and may represent very early cellular mediators of reperfusion
injury [9]. Thereby, immunomodulation of lymphocytes may offer
a novel approach to attenuate very early detrimental immune
responses to severe traumatic injury.
The innate role of lymphocytes offers the potential for targeting
lymphocytes in the setting of severe injury and hemorrhagic shock.
FTY720, an immunomodulator recently approved for the
treatment of multiple sclerosis, sequestrates lymphocytes to
secondary lymphoid organs and reduces circulatory lymphocytes
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[10,11,12]. Disruption of lymphocyte trafficking with FTY720
may also offer a therapeutic strategy for reperfusion injury
associated with hemorrhagic shock.
In this study, we demonstrate that lymphocyte sequestration
with FTY720 significantly improves reperfusion survival in a large
animal hemorrhagic shock model. FTY720 resulted in sequestra-
tion of central lymphocytes and appeared to attenuate innate
cellular and molecular activation following hemorrhagic shock.
Lymphocyte immunomodulation strategies offer an exciting and
widely applicable approach towards abrogating immune mediated
reperfusion injury in trauma and surgical patients.
Methods
Animal Preparation
The experiments reported herein were conducted in compliance
with the Animal Welfare Act and in accordance to the principles
set forth in the ‘‘Guide for the Care and Use of Laboratory
Animals,’’ Institute of Laboratory Animals Resources, National
Research Council, National Academy Press, 1996. The study was
approved by the National Medical Research Center Institutional
Animal Care and Use Committee (IACUC, protocol KO05-06)
and all procedures were performed in animal facilities approved by
the Association for Assessment and Accreditation for Laboratory
Animal Care International (AAALAC).
Male and female 3–12 month Yorkshire (Sus scrofa domestica)
swine weighing 25–35 kg were acquired from ABI Farms
(Donsboro, PA). Feed was withheld 12 hours before surgery.
Prior to surgery, animals were sedated and anesthesia induced
with intramuscular ketamine hydrochloride (12–20 mg/kg) and
xylazine (2.2 mg/kg) as well as atropine sulfate (0.05 mg/kg) to
decrease tracheal secretions. Mask ventilation with Isoflurane
(5.0%) was used to facilitate endotracheal intubation. Animals
were ventilated (Ohmeda 7800 series ventilator, Datex, Madison,
WI) at 12–15 breaths/min and tidal volume 10 mL/kg.
Anesthesia was maintained with Isoflurane (1.5–2.5%) in 21–
25% O2.
Following adequate anesthesia the right external and internal
jugular veins and carotid artery were isolated. A 9Fr dual-lumen,
tunneled Hickman catheter was placed in the external jugular vein
for drug infusion and blood collection during the survival period.
A 9Fr introducer sheath was placed in the internal jugular vein
and a 7.5Fr pulmonary artery catheter (PAC; Edwards Life
Sciences, Irvine, CA) was inserted for continuous hemodynamic
monitoring. An 18 G Angiocath was placed in the carotid artery
and mean arterial pressure (MAP) was continuously transduced. A
midline laparotomy was performed to expose the liver and isolate
the left lateral lobe. Urine was collected via bladder catheteriza-
tion. Rectal temperature was monitored continuously. Normo-
thermia (37uC) was maintained with a warming device (Model
505, Bair Hugger, Augustine Medical, Eden Prairie, MN).
Liver Injury and Resuscitation
All animal groups underwent a standardized liver injury and
resuscitation protocol. (Figure 1). A reproducible liver injury was
created by placing a ring clamp over the left lower lobe, 50% in
width and 3.5–5 mm from the apex, adjusting for the relative size
of the animal. The clamp was closed and a #10 blade was used to
lacerate the lobe from the top of the clamp through the remaining
width. The liver injury denoted the start of the pre-hospital phase
(Time 0). After 1 minute, the clamp was removed and the
remaining tissue excised, resulting in a 25% lobectomy, consistent
with a grade III liver injury. The hepatectomy specimen was
weighed and divided by animal weight (kg) and reported as
hepatectomy weight index (g/kg). Bleeding was spontaneous and
removed continually via suction and measured by weight. Blood
loss weight (g) was used to calculate estimated blood loss volume
(%). At 15 minutes, animals were infused 250 mL normal saline
(NS) over the next 60 minutes. This time point represents the
arrival of a first responder (e.g. medic) who has limited carrying
capacity. After 1 hour blood collection was discontinued and the
abdomen packed then closed with towel clips.
After a total of 2 hours, the pre-hospital phase was completed
and hospital arrival was simulated. This time point represents
arrival of the patient to a hospital with surgical capabilities. The
abdomen was reopened, residual blood suctioned, sponges
collected, and blood loss quantified by weight. The liver injury
was repaired with suture and the abdomen definitively closed.
Invasive lines were removed and the carotid artery repaired. One
unit of allogeneic whole blood (10 mL/kg) (Thomas Morris,
Reisterstown, MD) was administered for hemoglobin ,7 g/dL,
otherwise animals received additional NS at 10 mL/kg. Anesthe-
sia was stopped and the animals extubated.
Experimental Group
Animals in the FTY720 group were treated 15 min after liver
injury. FTY720 (0.3 mg/kg) (Cayman, Ann Arbor, MI) was
diluted in 250 mL NS and administered over 60 min in place of
the vehicle control infusion (250 mL NS).
Post-surgical care and Histology
Animals were allowed to eat a regular diet and drink water
following surgery. Buprenorphine (0.05–0.1 mg/kg IM/IV) was
administered every 6–12 hours if the animals demonstrated any
sign of pain. If the animals showed any sign of severe disability (e.g.
inability to ambulate, eat, drink), severe infection, or uncontrolled
pain, they were euthanized (Euthasol, Virbac AH, Fort Worth,
TX) and taken for necropsy. At the end of the survival period
(72 hours post-injury), surviving animals were euthanized and
taken for necropsy. Samples of the heart, lung, liver, kidney, small
intestine, mesenteric lymph node, and spleen were taken. A
portion of each sample was fixed in 10% neutral buffered
formalin. The formalin-fixed tissues were processed routinely,
paraffin embedded, sectioned at approximately 5 micron,
mounted on a glass slide and stained with Hematoxylin and
Eosin (H&E) for histological evaluation. The remaining portion
was stored in RNALater (Qiagen, Valencia, CA) or flash frozen
using liquid nitrogen.
Laboratory Data
Blood samples were collected at 0, 15, 30, 60, 90, and
120 minutes during the hemorrhage period and at 18, 24, 36,
48, and 72 hours during the survival period. Complete blood
counts with differential were obtained using an automated cell
counter (NDvia120 Hematology System, Siemens, Deerfield, IL).
Immunohistochemistry
Immunohistochemical detection of CD3
+ lymphocytes was
performed on sections of formalin fixed, paraffin embedded blocks
of lymph node and spleen. Tissue slides were deparaffinized using
xylene followed by graded baths of ethanol. A DAKO Autostainer
Plus Universal Staining System (DAKO, Carpenteria, CA) was
used for automated immunohistochemical staining. Antigen
retrieval was performed using Trilogy (Cell Marque, Rocklin,
CA) for 30 minutes. Rat, anti- human CD3, monoclonal antibody,
clone CD3–12, (Serotec, Raleigh, NC) was used at a dilution of
Lymphocyte Modulation Improves Shock Survival
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specific polyclonal antibody (BD Biosciences, San Jose, CA) was
applied as a secondary antibody at a 1:100 dilution for 30 minutes
at room temperature. The chromogen applied was 3, 39
Diaminobenzidine (DAKO, Carpenteria, CA) for 10 minutes.
The sections were counterstained with Hematoxylin (DAKO,
Carpenteria, CA). External negative controls were processed
identically as anti-CD3 but the primary antibody was substituted
with normal rat serum. A tissue sample was considered positive if
reactive cells, lymphocytes, demonstrated reactivity. An Automat-
ed Cellular Imaging System (ACIS, DAKO, Carpenteria, CA) was
used to quantify the anti-CD3 immunohistochemistry staining.
Immunohistochemical detection of MPO was performed on
sections of formalin fixed, paraffin embedded blocks of lung tissue.
Antigen retrieval was performed using Proteinase K (DAKO,
Carpenteria CA) for 30 minutes. Polyclonal rabbit, anti- human
MPO (DAKO, Carpenteria CA) was used at a ready to use
dilution and incubated at room temperature for 30 minutes.
Envision, anti-rabbit (DAKO, Carpenteria CA) was applied as a
secondary antibody for 30 minutes at room temperature. The
chromogen applied was 3, 39 Diaminobenzidine (DAKO,
Carpenteria, CA) for 10 minutes. The sections were counter-
stained with Hematoxylin (DAKO, Carpenteria, CA). Normal
serum controls were processed identically as with MPO but the
primary antibody was substituted with normal rabbit serum. A
tissue sample was considered positive if reactive cells, neutrophils,
demonstrated intracytoplasmic reactivity in conjunction with a
segmented nucleus. Neutrophils were noted mainly in circulation
in small septal vessels and in large vessels. Cells with appropriate
nuclear morphology and the presence of light to intensely reactive
granules were counted; 5 random 406fields were assessed.
RNA Extraction and Quantitative Real-Time Polymerase
Chain Reaction
Total RNA was isolated from liver tissue taken at necropsy
using Qiagen RNeasy Mini Kit (Qiagen Inc. Valencia, CA)
according to manufacturer’s instructions. RNA purity and
quantity were assessed by measuring the A260,A 280, and A230on
a Nanodrop Spectrophotometer (NanoDrop Technologies Inc.
Wilmington, DE). RNA quality was determined from the 28S/18S
rRNA ratio and RNA Integrity Number (RIN) using an Agilent
2100 BioAnalyzer (Agilent Technologies Inc. Santa Clara, CA).
RIN values for all specimens in this study were $6.5. Satisfactory
mRNA was available for FTY720 (n=7) and the vehicle control
(n=5) groups. Reverse transcriptions were performed using Roche
1
st Strand Synthesis kits (Roche Diagnostics Corporation,
Indianapolis, IN) according to the manufacturer’s protocol.
Quantitative real-time polymerase chain reaction (QRT-PCR)
was performed using the 7900HT Fast Real-Time PCR System
Figure 1. Experimental design. Liver injury was initiated at t=0. Uncontrolled hemorrhage occurred until 1 hour, at which time the abdomen was
packed and temporarily closed (pre-hospital phase). The animal was observed until 2 hours when hospital care was initiated. The liver was repaired
and the abdomen definitively closed. The animal was then observed for a total of 72 hours. Blood transfusion was administered as indicated.
Necropsy was performed when the animal expired or at 72 hours following euthanasia. The uncontrolled hemorrhage and pre-hospital phases were
considered the hemorrhage period, while the hospital care phase was considered the reperfusion period. In the experimental group, FTY720 (0.3 mg/
kg diluted in 250 mL of NS)) was administered 15 minutes following liver injury. Vehicle controls were treated with 250 mL of NS.
doi:10.1371/journal.pone.0034224.g001
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expression of 21 immune-related genes. Taqman chemistry was
used. Primers for 18S rRNA target were used as an internal
control for each reaction. Primers and probes for the targets of
interest were obtained from Applied Biosystems (Table 1). All
samples were run in duplicate. Individual samples were compared
to averaged control tissue expression. Transcript quantification
was derived using the comparative threshold cycle method and
reported as the mean n-fold difference of the experimental sample
to the control pool.
Statistical Analysis
Animals were randomly assigned to the vehicle control or
experimental FTY720 group. Survival analysis between groups
was performed by Kaplan Meier survival plots with the log rank
test. Continuous data was compared with the Student t-test or
nonparametric tests as appropriate. Multiple comparisons were
performed with one-way ANOVA. A one-way ANOVA with
repeated measures design was used for continuous time-dependent
comparisons. Statistical analysis was performed using SPSS (SPSS
Inc., Chicago, IL). A two-tailed p value ,0.05 was considered
statistically significant. All data is represented as means 6 standard
error of the mean (SEM) unless otherwise specified.
Results
We used a well-validated and clinically relevant swine liver
injury and resuscitation protocol with a 72 hour observation
period to simulate hemorrhagic shock [13,14]. Treatment animals
were administered FTY720 fifteen minutes following liver injury.
Both treatment and control groups underwent a standardized
resuscitation protocol. Animal characteristics were comparable
between vehicle control and the FTY720 treatment group
(Table 2). Despite similar liver injury delivery, percent mean
blood loss volume was lower in the FTY720 group compared to
vehicle control but this was not statistically significant. In addition,
blood transfusion requirements were identical between vehicle
control and FTY720 groups. Importantly, invasive hemodynamic
monitoring during the hemorrhage period demonstrated shock
physiology in all animal groups (Figure 2). Both vehicle control
and the FTY720 experimental group demonstrated a significant
reduction in mean arterial pressure and cardiac output with
elevation in heart rate compared to baseline. There were no
statistical differences between the vehicle control and experimental
hemodynamic profiles.
Overall survival in the FTY720 experimental group was
improved compared to control although not statistically significant
(Figure 3A). The overall survival was 22.2% (2/9) in the vehicle
control and 66.7% (6/9) in the FTY720 group (p=0.081). One
animal in both the FTY720 and vehicle control group died during
the hemorrhage period and were not included in the reperfusion
period (following hemorrhage) survival analysis. During the
reperfusion period survival was statistically improved in the
FTY720 group compared to control (Figure 3B). The reperfusion
survival was 25% (2/8) in the vehicle control and 75% (6/8) in the
FTY720 group (p=0.047). Thereby, disruption of the lymphocyte
response to shock during hemorrhage appeared to significantly
reduce mortality associated with reperfusion injury.
Total peripheral, or circulating, leukocytes were not different
during hemorrhage, but were significantly reduced during the
reperfusion period in the FTY720 group (Figure 4). We used anti-
CD3 immunohistochemistry staining of mesenteric lymph nodes
and spleen tissue at time of necropsy to evaluate central
lymphocyte sequestration (Figure 5). There was significant central
Table 1. RT-PCR targets with primer and probe sequences.
Target Forward Primer Reverse Primer Probe
IL-1a CTGAAGAAGAGACGGTTGAGTTTAAA AAGTTGTATTTCATGTTGCTCTGGAA CAGAAGAAGAAATCATCAAGCCCAGATCAGC
IL-1b TTGAATTCGAGTCTGCCCTGT CCCAGGAAGACGGGCTTT CAACTGGTACATCAGCACCTCTCAAGCAGAA
IL-6 AATGTCGAGGCTGTGCAGATT TGGTGGCTTTGTCTGGATTCT AGCACTGATCCAGACCCTGAGGCAAA
TNFa TGGCCCCTTGAGCATCA CGGGCTTATCTGAGGTTTGAGA CCCTCTGGCCCAAGGACTCAGATCA
EDN-1 CCTGCTCTTCCCTGATGGATAA GGACAATGTGTTCTGGAGTGTTG AGTGTGTCTACTTCTGCCACCTGGACATCA
INOS CGTTATGCCACCAACAATGG AGACCCGGAAGTCGTGCTT ATCAGGTCGGCCATCACCGTG
HIF-1a GCATTAAAGTTAGAACCAAATCCAGAGT AAGGACTAGCTGGCTGATCTTGA CTGGAACTTTCTTTTACCATGCCCCAGATT
HSP70 ACCATCGAGGAGGTGGATTAGA ATGAAGTGATACAGAACAGAACTAAAATACAG CCTCTTTGAGACCCAAGGACTTTGACATTGT
TGF-b1 AGGGCTACCATGCCAATTTCT CGGGTTGTGCTGGTTGTACA CCTAGACACTCAGTACAGCAAGGTCCTGGC
C3 CAAGAAATGATTGGTGGCTTCAA GACCTGTGGTTCACAGATGTCTTT AGCCTTTGTTCTCATCGCGCTGCA
TGFa CCCAGATTCCCACAGTCAGTTC AGCGTGCGCCGACGTA AAGCCAGCATGTGTCTGCCACTCTG
VCAM CTGTTCAAGTTGCTCCCAGGGAT GAGCAGGTCATGTTCACAGAACTG CGACCATCTCCGTCAACCCCTCC
IL-2 ACAGTTGCTTTTGAAGGAAGTTAAGAA CCTGCTTGGGCATGTAAAATTT CGAGAATGCTGATCTCTCCAGGATGCTC
CD154 GAAATGCACAAAGGCGATCA TGCTGTTTTACTACTGGCCTCG ATCCTCAAATTGCGGCACATGTCATAAG
BAX CTCAAGCGCATTGGAGATGA GTCCACGGCTGCGATCA TCCTCTGCAGCTCCATGTTACTGTCCAG
BCL-2 TTCTACTTTGTCAGGCTTATGAAGGTT TGTCCTTTGTCCCATAATAATTTTTTT CAGGTCTTTATTGCTACTCAATTTGAATCTTCCCA
FAS AATGGTATCGAAGAAACCAAAATAGAC CGGAGCAGCTGGACTTTCTG CATGCATGACAATCCCAAAGATACAGCTGA
FAS-L GGCAAGCCTAACTCAAGATCCA CATATACTTCACCCCAGAGACCAA CAATTCCATAGGTGTCTTCCCATTCCAGAGG
NF-kB CTGGCAGCTCTCCTCAAAGC CACGAGTCATCCAGGTCATACAG CTCAAAGTTCTCCACCAGGGGATCTGCTC
COX-2 CTGAACACCTCCGCTTTGC AAGCACATCGCACACTCTATTATGT CAGACCAGGCACCAGACCAAAGACCTC
PPLA-2 CTACTGTGGCCTAGGTGGATCAG TCTCTGTAGCAGTTGTCGTGTGTCT CGCAGCACCTGTCCAGTTCATCCAC
doi:10.1371/journal.pone.0034224.t001
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+ T lymphocyte sequestration in the FTY720 group
compared to control in both mesenteric lymph node and spleen
(Figure 5A). Interestingly, significant central CD3
+ T lymphocyte
sequestration was evident in the vehicle control group compared
to naı ¨ve swine mesenteric lymph node and spleen tissue
(Figure 5B). This finding suggests that some degree of T
lymphocyte sequestration is part of the normal response to
hemorrhagic shock. Importantly, FTY720 mediated peripheral
leukocyte reduction with central lymphocyte sequestration and
conferred a survival advantage in this liver injury model.
In order to study the innate cellular response to hemorrhagic
shock, we examined peripheral blood and tissue neutrophil levels
in the FTY720 and control groups. Neutrophils have been
established as mediators of injury following hemorrhage in both
animal and human studies [15,16,17]. During reperfusion,
peripheral blood neutrophil numbers were markedly increased in
the vehicle control group (Figure 6). This peripheral neutrophil
response was attenuated in the FTY720 group throughout the
reperfusion period. The tissue neutrophil response to hemorrhagic
shock was evaluated by examining lung tissue neutrophil
infiltration, a major target organ of neutrophils following shock
[18,19]. Neutrophil infiltration (H&E stained sections and
immunohistochemistry using anti-MPO antibody) in lung tissue
was significantly increased in vehicle control animals when
compared to naı ¨ve lung tissue (Figure 7). In contrast, lung tissue
neutrophils were significantly decreased in the FTY720 group
compared to control. These findings indicate that both the
peripheral blood and tissue neutrophil response was attenuated in
the FTY720 group, suggesting that lymphocyte manipulation also
disrupted the innate neutrophil response to hemorrhagic shock.
In order to evaluate the innate molecular response to
hemorrhagic shock, we analyzed gene transcripts of 21 inflam-
matory targets associated with IRI from liver tissue, a major
effector organ of the systemic immune response to shock (Table 1)
[6]. Expression of six gene targets were statistically different from
the control group when compared to the FTY720 group; the anti-
apoptotic gene BCL-2 was up-regulated and the apoptotic gene
FAS was down regulated; innate immunity genes HSP70, INOS,
and NFkB were down-regulated; the adhesion gene VCAM was
also down-regulated compared to vehicle control animals
Figure 2. Hemodynamic profiles during hemorrhage period for FTY720 and vehicle control (in this and subsequent figures control
is used for vehicle control) groups. a) Heart rate. b) Mean arterial pressure. c) Cardiac output. There were no statistical differences between the
control and experimental hemodynamic profiles.
doi:10.1371/journal.pone.0034224.g002
Table 2. Animal clinical parameters.
Variable Control (n=9) FTY720 (n=9) p-value
Mean animal weight [kg] 32.561.7 30.160.5 NS
1
Animal gender - M:F 5:4 5:4 NS
2
Mean hepatectomy weight index [g/kg] 0.3160.04 0.3760.04 NS
1
Mean blood loss volume % 46.863.4 34.364.9 NS
1
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apoptosisand liver inflammation at the molecular level following
hemorrhagic shock.
Discussion
In this study, we show that lymphocyte modulation with
FTY720 significantly improves reperfusion survival following
experimental hemorrhagic shock in a clinically relevant large
animal model. T lymphocyte sequestration appears to modulate
innate cellular and molecular activation following hemorrhagic
shock. Specifically, disruption of the innate lymphocyte response
resulted in significantly decreased circulating and lung tissue
infiltrating neutrophils and decreased expression of liver immune-
related genes. T lymphocytes mediate critical innate events
following hemorrhage, and lymphocyte modulation may amelio-
rate reperfusion injury.
The immune system is designed to respond to local injury and is
necessary for hemostasis, protection against microorganism
invasion, and initiation of tissue repair. Severe trauma and
hemorrhagic shock induce a systemic inflammatory response that
results in inappropriate immune activation and secondary injury to
the host. Severe injury provokes the simultaneous activation of
potent molecular and cellular components of innate immunity,
including complement, cytokines, chemokines, neutrophils, and
monocytes [20]. These innate events culminate with organ injury
to the host, manifesting clinically as the systemic inflammatory
response syndrome, acute respiratory distress syndrome, and
ultimately multi-organ dysfunction syndrome [1]. Modulation of
the immunologic response to injury is a major therapeutic goal to
reduce associated morbidity and mortality.
The majority of research on clinical therapeutics for ischemia
reperfusion injury has focused on monocyte and neutrophil
adhesion blockade. However, despite promising preclinical data,
results of phase 2 and 3 trials of neutrophil anti-adhesion therapy
in ischemia-reperfusion disorders have been disappointing [21]. In
two clinical trials testing humanized CD18 monoclonal antibodies
in the setting of traumatic injury, mortality and other primary end
points were not significantly affected [22,23]. These failures are
likely the result of the redundancy of adhesion pathways, but also
suggest that the neutrophil is not central in the innate immune
response to IRI.
Adaptive lymphocyte activation is conventionally described in
the presence of foreign antigen bound to self-MHC molecules
together with antigen-presenting cell costimulation signals. How-
ever, there is emerging evidence that lymphocytes are rapidly
activated in an alloantigen-independent manner in the setting of
IRI [24] [9]. Danger signals released in IRI may activate
lymphocytes and lead to innate function prior to classical adaptive
function [25]. Furthermore, hypoxia may be sufficient for
lymphocyte activation, as CD4
+ T lymphocytes have been shown
to increase adhesion to endothelial monolayers following anoxia
modulation [26,27]. The first direct proof of the role for T
lymphocytes in IRI was in a mouse liver ischemia model where a
marked preservation of liver function was found in T cell deficient
athymic (nu/nu) mice compared to wild type mice [7]. This was
associated with a decrease in neutrophil infiltration, which was
restored with adoptive transfer of wild type T cells into the
athymic mice. The role of T lymphocytes as critical cellular
mediators of the innate immune response to IRI has been
substantiated in multiple subsequent IRI models [6,7,8,28,29].
Altogether, these pre-clinical studies demonstrate a novel, innate
function of T lymphocytes in the setting of ischemic injury.
The innate role of T lymphocytes offers the potential for
targeting lymphocytes in the setting of severe injury and
hemorrhagic shock. FTY720 is a recently introduced immuno-
modulator that sequestrates T lymphocytes to secondary lymphoid
organs and reduces circulatory lymphocytes by targeting receptors
for sphingosine 1-phosphate. Specifically, FTY720 engages four of
the five known S1P receptors (S1P1, S1P3, S1P4, and S1P5). In
Figure 3. Kaplan-Meier survival curve for experimental groups
versus control with log-rank test for statistical comparison. a)
Overall survival. b) Reperfusion period survival. Dashed red line
indicates end of hemorrhage and beginning of reperfusion period.
doi:10.1371/journal.pone.0034224.g003
Figure 4. Peripheral leukocyte counts during hemorrhage and
reperfusion periods. Dashed line indicates end of hemorrhage and
beginning of reperfusion period. Leukocytes were significantly de-
creased during the reperfusion period in the FTY720 group (p=0.03).
Data is depicted as mean 6 SEM.
doi:10.1371/journal.pone.0034224.g004
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resulting in functional antagonism and internalization of S1P1
receptors on lymph-node T cells [30,31]. FTY720 has been shown
to ameliorate IRI in various animal models and T lymphocyte
modulation has been mechanistically implicated [32]. In a rat
renal transplant model, FTY720 treatment improved renal
function and reduced intragraft neutrophil infiltration despite no
change in adhesion molecules expression, highlighting the central
role of the T lymphocyte in IRI [33]. In a series of pilot
experiments using our porcine HS IRI model, we have
demonstrated the ability of T cell depletion using porcine anti-
thymocyte globulin (PATG) to produce the same effect as
described in this report further highlighting the central role of T
cells in hemorrhagic shock [34]. The overall survival was 22% (2/
9) in the control and 75% (6/8) in the PATG groups, p=0.09;
during the reperfusion period (following hemorrhage) survival was
25% (2/8) in the control and 100% (6/6) in the PATG groups,
p=0.008. Results from these studies suggest that the disruption of
the innate lymphocyte response to hemorrhagic shock appeared to
significantly reduce mortality associated with reperfusion injury.
However, these studies were limited by the need to pre-treat
animals and therefore only served as proof of concept. Here we
corroborate these findings in demonstrating that T lymphocyte
modulation following hemorrhage with FTY720 reduces innate
immune-mediated injury during reperfusion.
Neutrophils have been established as mediators of injury
following hemorrhage in both animal and human studies
[15,16,17]. In particular, neutrophils have been shown to mediate
acute lung injury following hemorrhagic shock, a significant
contributor to morbidity and mortality after injury [18,19].
Interestingly, T lymphocytes may coordinate innate neutrophil
action following ischemic injury. In an intestinal IRI model, T
lymphocytes were shown to orchestrate neutrophil trafficking [6].
Thereby, by disrupting T lymphocyte function in the setting of
hemorrhage, neutrophil action may also be affected. In the current
study, T lymphocyte depletion resulted in significant circulating
and tissue infiltration neutrophil inhibition. The circulating
neutrophil response was diminished during the reperfusion period
in FTY720 treated animals. In addition, lung neutrophil
infiltration was also significantly attenuated during reperfusion in
the lymphocyte depletion group. The reduction in lung tissue
neutrophil infiltration likely contributed to the improved survival
in the FTY720 treated animals. In sum, innate lymphocyte and
neutrophil function are intimately linked, and lymphocyte
disruption in the setting of hemorrhage appears to inhibit
neutrophil mediated immune injury.
Figure 5. Central lymphocyte counts at time of necropsy. a) Representative immunohistochemistry pictures (206magnification) of anti-CD3
staining of normal, control, and FTY720 mesenteric lymph node and spleen tissue. b) Quantification of anti-CD3 reactivity by ACIS. * indicates p,0.05
compared to normal, unmanipulated tissue; { indicates p,0.05 compared to control. Data is depicted as mean 6 SEM.
doi:10.1371/journal.pone.0034224.g005
Figure 6. Peripheral neutrophil counts during hemorrhage and
reperfusion periods. Dashed line indicates end of hemorrhage and
beginning of reperfusion period. Data is depicted as mean 6 SEM.
doi:10.1371/journal.pone.0034224.g006
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is noteworthy that the FTY720 treated animals appeared to lose
less blood than controls, although the difference was not
statistically different and all animals demonstrated shock physiol-
ogy after hemorrhage. Sphingosine 1-phosphate receptors are
present on vascular endothelium in addition to secondary
lymphatic organs, and have been shown to regulate vascular tone
[35]. In particular, FTY720 has been shown to reduce portal
pressure in a small animal model as well as stabilize pulmonary
and vascular endothelium [36]. Additionally, S1P places a role in
platelet aggregation suggesting the possibility of T lymphocyte
independent effects [37]. One possible role of these non T
lymphocyte mediated effects in hemorrhagic shock is that FTY720
activation of sphingosine 1-phosphate receptors on mesenteric
vascular endothelium results in relative splanchnic vasoconstric-
tion, resulting in decreased blood loss during visceral hemorrhage.
Although these findings confound the current experiment, it is
clearly a beneficial side effect of the therapeutic employment of
FTY720 for intra-abdominal hemorrhagic shock. FTY720 has also
been associated with significant bradycardia in clinical trials, also
related to sphingosine 1-phosphate receptors on cardiomyocytes
[38]. While not observed in the current experiment, drug induced
bradycardia would have obvious detrimental effects during
hemorrhage. Finally, while the role of the lymphocyte in early
innate immune activation is under intense investigation, the
precise mechanisms of lymphocyte mediated ischemia-reperfusion
injury have not been fully elucidated. Thereby, a complete
biological explanation for the survival advantage conferred by
lymphocyte disruption following hemorrhage is not yet available
but the ability of T cell manipulation by either sequestration or
depletion to ameliorate hemorrhagic shock suggest that this is
primarily a T lymphocyte and not a FTY720 mediated effect. In
order to fully address these questions future mechanistic studies are
warranted to clarify the role of lymphocytes in immune injury
following hemorrhage.
The current experiment demonstrates the novel use of a
lymphocyte modulator administered following hemorrhage in a
clinically relevant animal model. This lends to direct clinical
translation in which a lymphocyte therapeutic, such as FTY720,
can be administered during resuscitation of a trauma patient. In
addition, there is a large array of pharmacologic strategies
currently available that target lymphocyte function, primarily for
clinical use in the setting of transplantation and autoimmune
diseases. Humanized monoclonal antibodies, such as anti-CD52
mAb (Alemtuzumab), are well tolerated and may be clinically
applicable following significant hemorrhage or injury [39].
Figure 7. Lung tissue neutrophil infiltration at time of necropsy. a) Representative histology pictures (4006magnification) of normal, control
and PATG tissue. b) Quantification of anti-MPO reactivity. * indicates p,0.05 compared to normal, unmanipulated tissue. { indicates p,0.05
compared to control group. Data is depicted as mean 6 SEM.
doi:10.1371/journal.pone.0034224.g007
Figure 8. Inflammatory gene transcript expression in liver
tissue of FTY720 relative to the control group. Mean value of
relative fold expression is depicted on a logarithmic scale. * indicates
p,0.05 compared to control group.
doi:10.1371/journal.pone.0034224.g008
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components of the innate immune system may lead to harnessing
advancements in lymphocyte biology for novel hemorrhagic shock
therapies. We are currently exploring these potential therapeutic
pathways.
In conclusion, we show that lymphocyte sequestration with
FTY720 significantly improves reperfusion survival following
experimental hemorrhagic shock in a large animal model.
Lymphocyte immunomodulation appears to attenuate innate
cellular and molecular activation following hemorrhagic shock.
Specifically, disruption of the innate lymphocyte response resulted
in significantly decreased circulating and lung tissue infiltrating
neutrophils and decreased expression of liver inflammatory genes.
In conclusion, lymphocyte sequestration with FTY720 offers a
novel and clinically applicable approach towards abrogating
immune mediated reperfusion injury in trauma and surgical
patients.
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